Search
for
Sort by
Research 151–180 of 305
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- Nonclassic congenital adrenal hyperplasia
- Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females
- Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
- Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies
- Congenital adrenal hyperplasia
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis
- Study on the zona pellucida 4 (ZP4) gene sequence and its expression in the ovaries of patients with polycystic ovary syndrome
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Managing polycystic ovary syndrome in primary care
- PCOS: update and diagnostic approach
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
- Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age
- Menopausal Acne – Challenges And Solutions
- Menstrual Cycle Alterations during Adolescence: Early Expression of Metabolic Syndrome and Polycystic Ovary Syndrome
- Hyperandrogenism in Adolescent Girls
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
- Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population
- Hyperandrogenism in Adolescent Girls
- Hirsutism – From Diagnosis to Use of Antiandrogens
- The role of antimullerian hormone in the hormonal workup of women with persistent acne
- Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.
- Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Can serum vaspin levels predict clomiphene resistance in infertile women with PCOS?